Exact Mass: 357.1436974

cyclo-dopa 5-O-glucoside

(2S)-6-hydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

Cyclo-dopa 5-o-glucoside, also known as leucodopachrome 5-beta-D-glucoside, is a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Cyclo-dopa 5-o-glucoside is soluble (in water) and a moderately acidic compound (based on its pKa). Cyclo-dopa 5-o-glucoside can be found in a number of food items such as almond, gooseberry, apricot, and pepper (c. pubescens), which makes cyclo-dopa 5-o-glucoside a potential biomarker for the consumption of these food products.

Cyhalofop-butyl

CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8186; ORIGINAL_PRECURSOR_SCAN_NO 8182 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8182; ORIGINAL_PRECURSOR_SCAN_NO 8179 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3852 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3851 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3828; ORIGINAL_PRECURSOR_SCAN_NO 3825 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8179; ORIGINAL_PRECURSOR_SCAN_NO 8176 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3830; ORIGINAL_PRECURSOR_SCAN_NO 3828 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8167; ORIGINAL_PRECURSOR_SCAN_NO 8165 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8182; ORIGINAL_PRECURSOR_SCAN_NO 8180 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8172; ORIGINAL_PRECURSOR_SCAN_NO 8170 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3829; ORIGINAL_PRECURSOR_SCAN_NO 3826

deoxyviolaceinic acid

A pyrrolecarboxylic acid that is pyrrole-2-carboxylic acid which is substituted at position 3 by a 3-hydroxyindol-3-yl group at at position 5 by an indol-3-yl group.

protoviolaceinic acid

Rosiglitazone

5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate

Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFκB) levels fall and inhibitor (IκB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes; Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. It is being marketed as Avandia by the pharmaceutical company GlaxoSmithKline, both as a standalone preparation and in combination with metformin (Avandamet). Another combination drug approved by the FDA is Avandaryl (with glimepiride); Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFkB) levels fall and inhibitor (IkB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes . [HMDB] Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFκB) levels fall and inhibitor (IκB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes; Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. It is being marketed as Avandia by the pharmaceutical company GlaxoSmithKline, both as a standalone preparation and in combination with metformin (Avandamet). Another combination drug approved by the FDA is Avandaryl (with glimepiride); Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFkB) levels fall and inhibitor (IkB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole

2-(5-chloro-2H-Benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)phenol, 9ci

5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole is a fda approved for use in food-contact polymers. FDA approved for use in food-contact polymers

HMBOA-Glc

7-methoxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

Constituent of the roots of Coix lachryma-jobi (Jobs tears). (R)-2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-glucoside is found in many foods, some of which are coffee and coffee products, corn, alcoholic beverages, and tea. HMBOA-Glc is found in alcoholic beverages. HMBOA-Glc is a constituent of the roots of Coix lachryma-jobi (Jobs tears).

Cyclodopa glucoside

6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

Cyclodopa glucoside is found in brassicas. Cyclodopa glucoside occurs in red beet cabbage juic

Gravacridonetriol

2-[1,2-Dihydroxy-1-(hydroxymethyl)ethyl]-1,11-dihydro-5-hydroxy-11-methylfuro[2,3-c]acridin-6(2H)-one

Gravacridonetriol is found in herbs and spices. Gravacridonetriol is an alkaloid from Ruta graveolens (rue

3-(3,4-dimethoxyphenyl)-N-[2-(3-hydroxy-4-methoxyphenyl)ethyl]prop-2-enimidic acid

Niazimicin

N-[(4-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarbothioamide

Niazimicin is a glucosinolate and a naturally occurring thiocarbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers of niazimicin (niazimicin A and niazimicin B, respectively) differ in the orientation of the NH group with respect to sulfur. Constituent of Moringa oleifera (horseradish tree) (Moringaceae). Niazimicin A is found in fats and oils, herbs and spices, and green vegetables.

Cinacalcet

alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride

C21H21ClFNO (357.12956180000003)

Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. It is sold by Amgen under the trade name Sensipar in North America and Australia and as Mimpara in Europe. Cinacalcet is used to treat hyperparathyroidism (elevated parathyroid hormone levels), a consequence of parathyroid tumors and chronic renal failure. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

Haloperidol 1,2,3,6-tetrahydropyridine

4(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine hydrochloride

Haloperidol 1,2,3,6-tetrahydropyridine is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)

2-Methoxyacetaminophen glucuronide

(2S,3S,4S,5R,6S)-6-(4-acetamido-3-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

2-Methoxyacetaminophen glucuronide is classified as a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 2-Methoxyacetaminophen glucuronide is considered to be soluble (in water) and a moderately acidic compound.

[3H]Rosiglitazone

4-hydroxy-5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-2,3-dihydro-1,3-thiazol-2-one

C21H27NO2S (357.17624020000005)

2-(Bis(2-(2,6-dioxomorpholino)ethyl)amino)acetic acid

2-{bis[2-(2,6-dioxomorpholin-4-yl)ethyl]amino}acetic acid

C14H19N3O8 (357.1172094)

(3R,5R)-3-Butyl-3-ethyl-5-phenyl-4,5-dihydro-2H-1$l^{6},4-benzothiazepine 1,1-dioxide

Danofloxacin

1-cyclopropyl-6-fluoro-7-{5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Quinocarmycin analog

12-cyano-10-(hydroxymethyl)-8-methoxy-16-methyl-11,16-diazatetracyclo[11.2.1.0^{2,11}.0^{4,9}]hexadeca-4(9),5,7-triene-15-carboxylic acid

D000970 - Antineoplastic Agents

2,3-Dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydroxy-6H-dibenzo(a,g)chinolysin

3-[Bis(4-methoxyphenyl)methylidene]-1H-indol-2-one

3-[bis(4-methoxyphenyl)methylidene]-2,3-dihydro-1H-indol-2-one

Trelagliptin

2-{[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}-4-fluorobenzonitrile

C18H20FN5O2 (357.1600952)

Desmethyltetrahydropiperine sulfate

{2-hydroxy-5-[5-oxo-5-(piperidin-1-yl)pentyl]phenyl}oxidanesulphonic acid

N-Acetylnorgalanthamine acetate

N,O-Diacetyl-N-demethylgalanthamine

Rhopalotine

2-Demethyldemecolcine

2-Demethyl-N-methyl-N-deacetylcolchicine

Thaipetaline

10-O-Demethylthaicanine

Demecolceine

Penicidone C

Catuabine D

Delavaine

C20H20ClNO3 (357.1131640000001)

Rumbrin

Cephasamine

N-Methyldanguyelline

Porothramycin B

(+)-noroconovine

Toddaliopsin B

Fuligorubin A

Orientinine

7,11,14-Trihydroxy-2,13-dioxohetisane

Isocorydine-N-oxide

Corydine N-oxide

10-Norpluviine diacetate

10-O-Demethylpluviine diacetate

cis-Caseadine N-oxide

Phyllocryptonine

Discretine N-oxide

Marinacarboline C

A natural product found in Marinactinospora thermotolerans.

Danofloxacin-D3

SCHEMBL3300409

Nitrodenafil

N-[4-(Benzyloxy)phenyl]-N-(4-cyanobenzyl)urea

C16H15N5O5 (357.10731400000003)

O1-[(3,5-Dimethyl-4-isoxazolyl)carbonyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide

Oprea1_110196

JWH 018 4-hydroxyindole metabolite

(4-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

DTXSID301017815

JWH 018 5-hydroxyindole metabolite

(5-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

(6-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone

JWH 018 7-hydroxyindole metabolite

(7-hydroxy-1-pentyl-1H-indol-3-yl)naphthalen-1-yl)-methanone

1869980-05-1

UNII-B3EM4XQ2QX

SCHEMBL1079103

C18H22F3NO3 (357.15516980000007)

ZINC1025498

(1-butylindol-3-yl)-(4-methoxynaphthalen-1-yl)methanone

5-OH-JWH-018

({[Benzyl(2-cyanoethyl)amino]carbonyl}amino)(4-methylphenyl)dioxo-λ6-sulfane

CHEMBL3526291

(6aS)-1,2,10-trimethoxy-6-methyl-6-oxido-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-6-ium-9-ol

MMV676461

C21H19N5O (357.15895240000003)

MMV688361

4-Hydroxysarcocapnine (supplier named)

Epiporphyroxine

8-O-beta-D-glucopyranoside of 8-hydroxy-2-quinolone-4-carboxylic acid

CHEMBL1271051

Acetylcephalotaxine

1,3-Dihydroxy-4-[2-[2-(hydroxymethyl)oxiranyl]-2-hydroxyethyl]-10-methylacridine-9(10H)-one

(+)-northalbaicalidine|thalbaicaline|Thalibaicaline

Chromoazepinone C

cystodytin B|Cystodytins-Cystodytin B

Mazethramycin C

macrocidin A

2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-1,9-diol|5,6,13,13a-Tetrahydro-1,9-dihydroxy-2,3,10-trimethoxy-8H-dibenzochinolizin|Capaurimin|dl-Capaurimine

catuabin C

C19H19NO6

MCULE-2632208911

N-trans-feruloyl-4-O-methyldopamine

JBIR-87

Trigonostemine D

Trigonostemine C

Cystodytin A-Cystodytins

1-(2-(dimethylamino)ethyl)-4-hydroxy-3,5,6-trimethoxy-9H-fluoren-9-one|caulophylline A

3-Demethoxy-2,3-methylenedioxyerythroculine|3-demethoxy-2alpha,3alpha-methylenedioxyerythroculine

Norpreoxoteine

(+)-11beta-methoxyerysotramidine

Colchicine, N-deacetyl-N-formyl-2,3-O-didemethyl-

shrilankine|Srilankin

Chromoazepinone A

SCHEMBL11258273

10,11-dihydroxy-3,4-dimethoxy-6-methyl-5,7,8,14-tetrahydro-6H-dibenzo[c,g]azecin-13-one|Vaillantin|Vaillantine

(-)-8-oxopolyalthiaine|2,8,10-trihydroxy-3,9-dimethoxy-5,6,12,12a(S),6a-pentahydroisoquinolino-(2,1-b)-isoquinolin-7-one

(+)-10,11-dioxoerythratidinone

Cystodytin A

DTXSID601018131

His Val Cys

Val Cys His

His Met Ala

Ser His Asp

Thr Thr His

His Ala Met

Ser Asp His

Pro Asn Gln

Ala His Met

Ala Met His

His Asp Ser

Thr His Thr

Asn Pro Gln

Met Ala His

Asp His Ser

DTXSID301017865

Pro Gln Asn

Cys Val His

His Ser Asp

His Cys Val

Asp Ser His

Met His Ala

Cys His Val

3-Acetylindicine N-oxide

C17H27NO7 (357.1787432)

Benzyladenosine

(2R,3R,4S,5R)-2-(6-(benzylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol

N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5]. N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5]. N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5].

Danofloxacin

Danofloxacine

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3664 CONFIDENCE standard compound; INTERNAL_ID 1027

rosiglitazone

5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, monopotassium salt

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)

NCGC00380403-01_C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)-

C15H19NO9_2H-1,4-Benzoxazin-3(4H)-one, 2-(beta-D-glucopyranosyloxy)-7-methoxy-, (2R)

NCGC00385508-01_C15H19NO9_2H-1,4-Benzoxazin-3(4H)-one, 2-(beta-D-glucopyranosyloxy)-7-methoxy-, (2R)-

Rosigltazone

C19H20ClN3O2 (357.12439700000004)

Loxapine-7-methoxy

HMBOA + O-Hex

Annotation level-3

Carabersat

C16H15N5O5 (357.10731400000003)

CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3829; ORIGINAL_PRECURSOR_SCAN_NO 3826 C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3735; ORIGINAL_PRECURSOR_SCAN_NO 3733 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3830; ORIGINAL_PRECURSOR_SCAN_NO 3828 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3784; ORIGINAL_PRECURSOR_SCAN_NO 3782 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3852 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8151; ORIGINAL_PRECURSOR_SCAN_NO 8147 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8221; ORIGINAL_PRECURSOR_SCAN_NO 8218 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8179; ORIGINAL_PRECURSOR_SCAN_NO 8176 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8256; ORIGINAL_PRECURSOR_SCAN_NO 8254 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8172; ORIGINAL_PRECURSOR_SCAN_NO 8170 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8204; ORIGINAL_PRECURSOR_SCAN_NO 8203

1,N2-Benzoquinone-deoxyguanosine

O6-Benzyl-deoxyguanosine

4-nitrobenzo-18-crown-6

"MLS001047529-01!3-(diethylamino)propyl 2,2-diphenylacetate"

C16H23NO8 (357.1423598)

Ala Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

Ala Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

Ala Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

Ala Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

Ala Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

Ala Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

Gly Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

Gly Ala Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

Gly Gly Pro Gln

(2S)-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

Gly Gly Gln Pro

(2S)-1-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

Gly Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

Gly Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

Gly Pro Ala Asn

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-3-carbamoylpropanoic acid

Gly Pro Gly Gln

(2S)-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

Gly Pro Asn Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]propanoic acid

Gly Pro Gln Gly

2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]acetic acid

Gly Gln Gly Pro

(2S)-1-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

Gly Gln Pro Gly

2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

Met Ala His

Asn Gln Pro

His Val Cys

Cys Val His

His Thr Thr

Asn Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

Asn Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

His Ala Met

Ala Met His

Asn Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

Asn Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

Asn Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

Asn Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

His Cys Val

Val His Cys

Pro Ala Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

Pro Ala Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

Gln Pro Asn

Val Cys His

Pro Gly Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

Pro Gly Gly Gln

(2S)-4-carbamoyl-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)butanoic acid

Pro Gly Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

Pro Gly Gln Gly

2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]acetic acid

Pro Asn Ala Gly

2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

Pro Asn Gly Ala

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

Pro Gln Gly Gly

2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}acetic acid

Cys His Val

Gln Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

Gln Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

Ala His Met

Gln Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

Met His Ala

Gln Asn Pro

His Met Ala

JWH 018 2-hydroxyindole metabolite

(2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

JWH 018 6-hydroxyindole metabolite

(6-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

JWH 018 N-(5-hydroxypentyl) metabolite

(1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone

JWH 073 N-butanoic acid metabolite

4-(3-(1-naphthoyl)-1H-indol-1-yl)-butanoic acid

Cinacalcet

[(1R)-1-(naphthalen-1-yl)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

Gravacridonetriol

2-[1,2-Dihydroxy-1-(hydroxymethyl)ethyl]-1,11-dihydro-5-hydroxy-11-methylfuro[2,3-c]acridin-6(2H)-one

Cyclodopa glucoside

6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

Isradipine Metabolite (2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.)

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, mono(1-methylethyl) ester

2-Gmbo

7-methoxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol

2-(5-chloro-2H-Benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)phenol, 9ci

(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite

(±)-JWH 018 N-(3-hydroxypentyl) metabolite

(±)-JWH 018 N-(2-hydroxypentyl) metabolite

6-Acetyl-10b-hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

Ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(1-T-butoxycarbonyl-1-methyl)ethoxyimino acetate

C18H20ClN5O (357.13563000000005)

4-CHLORO-N-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE

3-FLUORO-4-FORMYLPHENYLBORONICACID

Etibendazole

Carbamic acid,N-[6-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]-1H-benzimidazol-2-yl]-, methylester

C18H16FN3O4 (357.1124788)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

(4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE

Cyproquinate

3-Quinolinecarboxylicacid, 6,7-bis(cyclopropylmethoxy)-4-hydroxy-, ethyl ester

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent

1-(5-methoxy-2-methyl-4-nitrophenyl)-4-(2-methylsulfonylethyl)piperazine

C21H27NO2S (357.17624020000005)

4-ISOTHIOCYANATOPHENYL 4-PENTYLBICYCLO

2,4,6-Triphenoxy-1,3,5-triazine

Etersalate

D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Fmoc-OBT

(S)-(+)-3-METHYL-2-BUTYLAMINE

Z-Asp(OBzl)-OH

C20H20ClNO3 (357.1131640000001)

Fmoc-Val-Cl

1,3,5-Tris(aminomethyl)-2,4,6-triethylbenzene trihydrochloride

C15H30Cl3N3 (357.15051900000003)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-[3-(trifluoromethyl)benzoyl]- (9CI)

C19H14F3N3O (357.108891)

2-Methyl-2-propanyl 4-[4-(trifluoromethyl)benzoyl]-1-piperidineca rboxylate

C18H22F3NO3 (357.15516980000007)

5-[[p-(benzylmethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium chloride

C18H22ClN6 (357.1594382)

8-METHOXY LOXAPINE

C19H20ClN3O2 (357.12439700000004)

Hasubanan-7-one,5,6-didehydro-4,6-dimethoxy-17-methyl-2,3-[methylenebis(oxy)]-

2-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide

C20H27NO3Si (357.1760112)

Cafedrine

(-)-Cafedrine

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

5-(aminosulphonyl)-N-[[1-(2-hydroxyethyl)-2-pyrrolidinyl]methyl]-2-methoxybenzamide

8-benzyloxy-2-deoxyadenosine

TERT-BUTYL N-[5-(TOSYLOXY)PENTYL]CARBAMATE

C17H27NO5S (357.1609852)

4,7-dimethyl-5,6-bis(phenylmethoxy)-1H-indole

C19H20ClN3S (357.1066390000001)

10-(2-chloroethyl)-6-piperazin-1-ylbenzo[b][1,4]benzothiazepine

Methyl 3-amino-2-[[(2-cyanobiphenyl-4-yl)methyl]amino]benzoate

2-ALLYL-1-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-2-YL)-6-(METHYLTHIO)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3(2H)-ONE

C17H19N5O2S (357.1259394)

(R)-(-)-5-(TRITYLOXYMETHYL)-2-PYRROLIDONE

TERT-BUTYL ACETYL(3-ACETYL-7-METHOXYNAPHTHALEN-1-YL)CARBAMATE

O3-Acetylcephalotaxine

4-TERT-BUTOXYCARBONYLAMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID BENZOTRIAZOL-1YL ESTER

Z-Asp-OBzl

C17H23BF3NO3 (357.17229940000004)

4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)phenyl]morpholine

Trelagliptin

C18H20FN5O2 (357.1600952)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

4-hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide

4-Hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihy dro-3-quinolinecarboxamide

Z-D-Asp-OBzl

2-CHLORO-3-NITROBENZOICACID

C15H16BF4N3S (357.1094054)

phenyl (3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate

C19H21BFNO4 (357.1547588)

(4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one

2-({6-[(3R)-3-Amino-1-piperidinyl]-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl}methyl)benzamide

(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

C18H20FN5O2

C18H20FN5O2 (357.1600952)

N,N-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide

C14H19N3O8 (357.1172094)

2-bromo-9-octyl-9H-carbazole

C20H24BrN (357.1092004)

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine

Cinacalcet Impurity 13

(aR,bS)-rel-a-Hydroxy-b-[[(phenylmethoxy)carbonyl]amino]-benzenebutanoic acid

C16H27N3O4S (357.17221820000003)

N-Biotinyl-6-aminohexanoic acid

6-[5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-4-YL)-pentanoylamino]-hexanoic acid

7-Chloro-N-(4-fluoro-3-{[(2-methyl-2-propanyl)amino]methyl}phenyl )-4-quinolinamine

C20H21ClFN3 (357.14079480000004)

Olorinab

C18H20ClN5O (357.13563000000005)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Bfpet F-18

C24H19FP+ (357.1208336)

6-Cyclohexylmethoxy-2-(3-chloroanilino) purine

(2S,3R)-N-(2-(3-Pyridinylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)-3,5-difluorobenzamide

C20H21F2N3O (357.16526)

2-Biphenyl-4-yl-6-fluoro-3-methyl-quinoline-4-carboxylic acid

C23H16FNO2 (357.1165008)

Piperidine, 4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)-, hydrochloride (1:1)

C18H19ClF3NO (357.110719)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

4-(4-(4-Chlorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-1-(4-fluorophenyl)-1-butanone

C21H21ClFNO (357.12956180000003)

3-[Bis(4-methoxyphenyl)methylidene]-1H-indol-2-one

1-Cyclopropyl-6-fluoro-7-(5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-4-oxoquinoline-3-carboxylic acid

9,10,11-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,3-diol

3-Methoxyacetaminophen glucuronide

(+)-Rosiglitazone

Rosiglitazone, (S)-

4-(2-Pyridyl)piperazinyl 3,4,5-trimethoxyphenyl ketone

C19H20ClN3O2 (357.12439700000004)

2-[[6-(4-ethylphenyl)-3-pyridazinyl]thio]-N-(2-oxolanylmethyl)acetamide

C19H23N3O2S (357.1510898)

4-[3-(2-chloroacetyl)-2,5-dimethyl-1H-pyrrol-1-yl]-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

3-[[2-(3,5-Dimethylpyrazol-1-yl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]amino]propan-1-ol

C18H23N5OS (357.1623228)

N-(6-acetamido-3-prop-2-enyl-1,3-benzothiazol-2-ylidene)cyclohexanecarboxamide

C19H23N3O2S (357.1510898)

4-[[2-(Phenylmethyl)-1-benzimidazolyl]sulfonyl]morpholine

L-Aspartic acid, L-histidyl-L-seryl-

Butachlor sulfonic acid

C17H27NO5S (357.1609852)

1,3,5-Triphenyl-1,3,5-triazinane-2,4,6-trione

3-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-5-methoxy-1,1-biphenyl-2-olate

C13H21N6O4S+ (357.13449260000004)

[2-(aminooxy)ethyl]{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}methylsulfonium (non-preferred name)

(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One

Ethyl 5-[2-(mesitylamino)-1,3-thiazol-4-yl]isoxazole-3-carboxylate

C21H19N5O (357.15895240000003)

5-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-3-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1,2-oxazole

N-Deacetylcolchicine

Orinocin

C16H21O9- (357.11855160000005)

10-Deoxygeniposidate

4-O-methyl-DIBOA-glucoside

(Z)-7-[(2S)-2-azaniumyl-2-carboxylatoethyl]sulfanyl-2-[[(1R)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate

C16H25N2O5S- (357.14841)

2-Methoxyacetaminophen glucuronide

A beta-D-glucosiduronic acid that is 2-methoxyacetaminophen in which the phenolic hydrogen is replaced by a beta-D-glucuronosyl group.

Desmethyltetrahydropiperine sulfate

Protubonine A

An organic heterotetracyclic compound that is 6,10b,11,11a-tetrahydro-H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-,4(3H,5aH)-dione substituted by an acetyl group at position 6, a hydroxy group at position 10b and a 2-methylpropyl group at position 3. It has been isolated from in Aspergillus species. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

Pipemidic acid trihydrate

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

HMBOA D-glucoside

(S)-methyl 4-(6-benzyl-4-oxo-4H-pyran-3-carboxamido)-2-methyl-4-oxobutanoate

C21H19N5O (357.15895240000003)

A natural product found in Aspeciesrgillus species.

1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-o-tolylurea

1,7,7-trimethyl-9-oxo-N-(2-oxolanylmethyl)-8H-furo[3,2-f][1]benzopyran-2-carboxamide

N-(9-acridinyl)-2-(3-methylphenoxy)acetohydrazide

4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide

N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

C23H20FN3 (357.1641172)

5-(2-Furanyl)-2-[(2-phenylanilino)methylidene]cyclohexane-1,3-dione

1-(4-Ethoxyphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea

6-(4-Ethoxy-3-methoxyphenyl)-3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylic acid methyl ester

C13H21N6O4S+ (357.13449260000004)

(2-Aminooxy-ethyl)-[5-(6-amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-methyl-sulfonium

4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide

3-[3-[[2-oxo-2-(1,2,5-trimethyl-3-pyrrolyl)ethyl]thio]propyl]-1H-benzimidazol-2-one

C19H23N3O2S (357.1510898)

N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide

4-(4-Methoxyanilino)-2,5-dimethyl-6-thieno[2,3-d]pyrimidinecarboxylic acid ethyl ester

C23H20NOP (357.12824400000005)

1-[2-(2,5-dimethyl-1H-indol-3-yl)ethyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea

C19H23N3S2 (357.1333318)

6-[[4-(3-methylphenyl)-5-(propan-2-ylthio)-1,2,4-triazol-3-yl]methyl]-1H-pyrimidine-2,4-dione

C17H19N5O2S (357.1259394)

6-[[[1-(2,6-dimethylphenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine

C15H19N9S (357.1484054)

2-(Diphenylphosphanyl)-1-(2-methoxyphenyl)-1H-pyrrole

N-[5-fluoro-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydrochloride

C16H21ClFN3O3 (357.12553980000007)

N-[3-[[2-furanyl(oxo)methyl]amino]phenyl]-1-isoquinolinecarboxamide

2-amino-4-(3-ethoxy-4-oxo-1-cyclohexa-2,5-dienylidene)-5,6-dihydro-1H-benzo[h]quinoline-3-carbonitrile

C11H22N2O9P- (357.10628720000005)

N(6)-(3-O-phospho-D-ribulosyl)-L-lysine

Ser-His-Asp

Cilastatin(1-)

C16H25N2O5S- (357.14841)

The anion resulting from the removal of a proton from a carboxylic acid group of cilastatin.

Thr-Thr-His

Asp-His-Ser

Asn-Pro-Gln

Asp-Ser-His

Gln-Pro-Asn

His-Asp-Ser

His-Thr-Thr

Ser-Asp-His

4-hydroxy-1-(2-methylpropyl)-N-(4-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

Vaillantine

Hycanthone(1+)

C20H25N2O2S+ (357.163665)

Ala-His-Met

Ala-Met-His

Asn-Gln-Pro

Cys-Val-His

His-Val-Cys

Pro-Asn-Gln

Pro-Gln-Asn

Met-His-Ala

Cys-His-Val

Gln-Asn-Pro

His-Ala-Met

His-Cys-Val

His-Met-Ala

Met-Ala-His

Thr-His-Thr

Val-Cys-His

Val-His-Cys

C11H22N2O9P- (357.10628720000005)

3-aminopropyl N-acetyl-alpha-D-glucosamine-1-phosphate(1-)

(E)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(3-hydroxy-4-methoxyphenyl)prop-2-enamide

N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-2-[(2-phenoxyacetyl)amino]acetamide

2alpha-(beta-D-Glucopyranosyloxy)-7-methoxy-2H-1,4-benzooxazine-3(4H)-one

2-Amino-3-[(3-hexanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C12H24NO9P (357.1188624)

N-[2-Benzyl-2-amino-2-(3-pyridyl)ethyl]phthalimide

cyclo-dopa 5-O-glucoside

2-(2-Hydroxy-3,5-di-tert-butylphenyl)-5-chlorobenzotriazole

HMBOA-Glc

O-ethyl N-[[4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphenyl]methyl]carbamothioate

HMBOA beta-D-glucoside

A beta-D-glucoside derived from 2-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine.

cyclodopa 5-beta-D-glucoside

An indolyl carbohydrate that is cyclodopa in which the phenolic hydrogen at position 5 has been replaced by a beta-D-glucosyl residue.

LPC 4:1;O2

C12H24NO9P (357.1188624)

His-Ser-Asp

ST 18:5;O3;Gly

AKT Kinase Inhibitor

C16H19N7O3 (357.1549304)

AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1].

NEO 376

NEO 376 is a selective modulator of 5-HT1 receptor, GABA receptor and dopamine receptor, with anti-psychotic actively.

3-[(2r)-4-[(2e,4e,6e,8e,10e)-dodeca-2,4,6,8,10-pentaenoyl]-3-hydroxy-1-methyl-5-oxo-2h-pyrrol-2-yl]propanoic acid

(10s)-5,6,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaen-11-ium-11-olate

2,4,11-trihydroxy-3,10-dimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

C20H20ClNO3 (357.1131640000001)

6-[9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

(10s)-14-hydroxy-3,4,5-trimethoxy-10-(methylamino)tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

12-hydroxy-2,3,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid

methyl 3,5-dimethoxy-2-{4-oxo-6-[(1e)-prop-1-en-1-yl]-1h-pyridine-3-carbonyl}benzoate

methyl (1r,3s,7r)-17-methoxy-4,6-dioxa-12-azapentacyclo[10.8.0.0¹,⁹.0³,⁷.0¹⁵,²⁰]icosa-8,15(20),16,18-tetraene-18-carboxylate

2-methoxy-3,5-dimethyl-6-[(2r,4z)-4-[(4-nitrophenyl)methylidene]oxolan-2-yl]pyran-4-one

14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-2-ol

(9s,10r)-3-hydroxy-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-ium-10-olate

5,7,8,11-tetramethoxy-4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-2-one

4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphene-3,12-diol

ethyl 1-sulfanyl-n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)methanimidate

(1r,5s,13s,17s)-10,14,15-trimethoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,14-tetraen-16-one

acetylcephalotaxine